Medication info
Candesartan Tablets 8 mg (Candesartan Cilexetil)

Candesartan Tablets 8 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
A bright pink tablet, round and convex on both sides with a dividing line on one side
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201403518 · Approved 2014.07.31 · Insurance code 657805320

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Elderly patients: No adjustment of the initial dose is necessary. Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. Elderly patients and patients with intravascular volume depletion, renal impairment, or mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension: Safety and efficacy have not been established in adolescents and children aged 18 years and younger. 2. Heart failure: Safety and efficacy have not been established in adolescents and children aged 18 years and younger.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • left ventricular contractile dysfunction
  • heart failure
View approved original text

This medication is primarily used to treat essential hypertension. It is also used in patients with heart failure symptoms due to decreased left ventricular contractility, where additional treatment with ACE inhibitors is required or ACE inhibitors are not well tolerated. This helps in controlling blood pressure and improving heart function. Therefore, this medication is used to effectively improve the symptoms of hypertension and certain heart failure patients.

How to take

Adult dose

This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Elderly patients: No adjustment of the initial dose is necessary. Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. Elderly patients and patients with intravascular volume depletion, renal impairment, or mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension: Safety and efficacy have not been established in adolescents and children aged 18 years and younger. 2. Heart failure: Safety and efficacy have not been established in adolescents and children aged 18 years and younger.

Precautions

This medication may cause serious harm to the fetus and newborn, especially during pregnancy. Therefore, it should be discontinued immediately if pregnancy is confirmed. It should not be used in patients with an allergy to this medication or who are pregnant, patients with severe liver impairment or cholestasis, a history of angioedema, primary hyperaldosteronism, and certain genetic lactose intolerant patients. Caution should be exercised when administering this medication to elderly patients or those with hyperkalemia, liver dysfunction, heart valve issues, ischemic heart disease, renal artery stenosis, or impaired renal function. Side effects such as dizziness, back pain, and respiratory infections may occur during this medication, and in heart failure patients, hypotension, hyperkalemia, and renal function damage may occur, necessitating regular blood tests. Symptoms such as sudden low blood pressure, shock, fainting, or loss of consciousness may appear, so if these symptoms occur, immediate consultation with a medical professional is necessary. This medication may enhance the effects when used with other antihypertensives, and special caution is warranted when used in combination with certain diuretics or potassium-sparing medications as blood potassium levels may dangerously rise. It is advisable for pregnant or breastfeeding women to avoid using this medication, and, if absolutely necessary, breastfeeding should be discontinued. The safety and efficacy for children and adolescents under 18 years of age have not been established, so use should be avoided. In elderly patients, caution should be taken to avoid excessive blood pressure lowering that may increase the risk of stroke. In the event of overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may occur, and in such cases, the patient should be stabilized and receive prompt medical treatment. This medication should be stored out of reach of children and should not be transferred to other containers.

Side effects

  • dizziness
  • low back pain
  • respiratory infection
  • upper respiratory infection
  • pharyngitis
  • rhinitis
  • fatigue
  • peripheral edema
  • chest pain
  • headache
Show 70 more
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • joint pain
  • proteinuria
  • asthenia
  • fever
  • sensory disturbance
  • dyspepsia
  • gastritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hypokalemia
  • hyponatremia
  • hypoglycemia
  • weakness
  • hunger
  • cold sweat
  • tremor
  • decreased concentration
  • convulsions
  • altered consciousness
  • increased liver enzyme levels
  • hepatitis
  • liver dysfunction
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • renal dysfunction
  • acute kidney injury
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • tension increase
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbance
  • decreased libido
  • forgetfulness
  • loss of appetite
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Additionally, avoid extremely cold or hot places, and it is recommended to store it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

A bright pink tablet, round and convex on both sides with a dividing line on one side

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.